SCHEMBL21687786

SCHEMBL21687786

N#Cc1cccc(-n2c3ccccc3c3ccccc32)c1-c1c(C#N)cccc1[Si](c1ccccc1)(c1ccccc1)c1ccccc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.36
HIF1A Q16665 1/20 0.36
ALDH1A1 P00352 4/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
TDP1 Q9NUW8 2/20 0.35
TSHR P16473 1/20 0.35
MAPT P10636 2/20 0.35
CA1 P00915 1/20 0.34
CA2 P00918 1/20 0.34
STAT3 P40763 1/20 0.34
IMPDH2 P12268 1/20 0.33
KDM4E B2RXH2 2/20 0.33
ATM Q13315 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
HTT P42858 2/20 0.32
ELANE P08246 1/20 0.32
NOTUM Q6P988 1/20 0.32
AR P10275 1/20 0.31
HSD17B10 Q99714 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21688071 0.91 HRH1 (0.34) SMN1; SMN2HIF1AALDH1A1MEN1KMT2A
SCHEMBL21687982 0.90 SMN1; SMN2 (0.35) SMN1; SMN2HIF1AALDH1A1MEN1KMT2A
SCHEMBL21687980 0.90 SMN1; SMN2 (0.35) SMN1; SMN2HIF1AALDH1A1MEN1KMT2A
SCHEMBL21687764 0.88 SMN1; SMN2 (0.41) SMN1; SMN2HIF1AALDH1A1MEN1KMT2A
SCHEMBL21687769 0.87 SMN1; SMN2 (0.38) SMN1; SMN2HIF1AALDH1A1CA1CA2
SCHEMBL21687763 0.85 SMN1; SMN2 (0.35) SMN1; SMN2HIF1AALDH1A1MEN1KMT2A
SCHEMBL19062208 0.85 CA1 (0.44) SMN1; SMN2HIF1AALDH1A1MEN1KMT2A
SCHEMBL21687456 0.85 SMN1; SMN2 (0.39) SMN1; SMN2HIF1AALDH1A1MEN1KMT2A
SCHEMBL21687767 0.84 SMN1; SMN2 (0.34) SMN1; SMN2HIF1AALDH1A1MEN1KMT2A
SCHEMBL21687726 0.84 SMN1; SMN2 (0.36) SMN1; SMN2HIF1AALDH1A1TDP1CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11201300-B2 Condensed cyclic compound and organic light-emitting device including condensed cyclic compound SAMSUNG ELECTRONICS CO., LTD. (KR) 2021-12-14 US disclosed
US-20200044168-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING CONDENSED CYCLIC COMPOUND SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-02-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200044168-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING CONDENSED CYCLIC COMPOUND CRY1, CCNL2, CCNE2 SMN1; SMN2 4039/4885HIF1A 622/4885ALDH1A1 616/4885
US-11201300-B2 Condensed cyclic compound and organic light-emitting device including condensed cyclic compound CRY1, CCNL2, CCNE2 SMN1; SMN2 4039/4885HIF1A 622/4885ALDH1A1 616/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.